chlorzoxazone has been researched along with Dyskinesia Syndromes in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BIANCONI, B | 1 |
| ZAMPORLINI, M | 1 |
1 other study available for chlorzoxazone and Dyskinesia Syndromes
| Article | Year |
|---|---|
[Oferol (combination of chlorzoxazone and pyramidone) in the treatment of disease of the locomotor apparatus].
Topics: Aminopyrine; Antipyrine; Chlorzoxazone; Movement Disorders; Physical Therapy Modalities; Zoxazolamin | 1962 |